Insider · CIK 0001453140

DE Silva Rajiv

CIK 0001453140 Name as filed on the most recent filing

Filed as DE Silva Rajiv (11)

15 transaction lines · from 11 filings · filed 2009-03-03 to 2022-11-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

15 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-11-18 P, Open-market purchase Venus Concept Inc.VERO 250,000, acquired Open Form 4 filing 0001567619-22-020779
2016-03-07 P, Open-market purchase Endo International plcENDP 100,125, acquired Open Form 4 filing 0001209191-16-106481
2015-11-11 P, Open-market purchase Endo International plcENDP 500,013, acquired Open Form 4 filing 0001209191-15-079480
2012-11-08 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 4,125,676, disposed Open Form 4 filing 0000885590-12-000075
2012-11-06 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 6,542,606, disposed Open Form 4 filing 0000885590-12-000074
2012-11-06 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 5,458,279, disposed Open Form 4 filing 0000885590-12-000074
2012-11-06 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX Not reported Open Form 4 filing 0000885590-12-000074
2012-05-24 P, Open-market purchase Amag Pharmaceuticals Inc.AMAG Not reported Open Form 4 filing 0001242616-12-000011
2011-08-12 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 249,666, acquired Open Form 4 filing 0000885590-11-000059
2010-12-01 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 2 lines 5,937,219, disposed Open Form 4 filing 0000885590-10-000063
2010-06-09 S, Open-market sale Valeant Pharmaceuticals InternationalVRX 2 lines 1,040,568, disposed Open Form 4 filing 0001209499-10-000056
2009-08-24 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 224,995, acquired Open Form 4 filing 0001209499-09-000074
2009-02-27 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 200,305, acquired Open Form 4 filing 0001209500-09-000035

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 7
  • Open-market sale 8
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DE SILVA RAJIV, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001453140

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.